These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34530383)

  • 1. A tacrine-tetrahydroquinoline heterodimer potently inhibits acetylcholinesterase activity and enhances neurotransmission in mice.
    Ip FCF; Fu G; Yang F; Kang F; Sun P; Ling CY; Cheung K; Xie F; Hu Y; Fu L; Ip NY
    Eur J Med Chem; 2021 Dec; 226():113827. PubMed ID: 34530383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease.
    Hepnarova V; Korabecny J; Matouskova L; Jost P; Muckova L; Hrabinova M; Vykoukalova N; Kerhartova M; Kucera T; Dolezal R; Nepovimova E; Spilovska K; Mezeiova E; Pham NL; Jun D; Staud F; Kaping D; Kuca K; Soukup O
    Eur J Med Chem; 2018 Apr; 150():292-306. PubMed ID: 29533874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents.
    Babaee S; Chehardoli G; Akbarzadeh T; Zolfigol MA; Mahdavi M; Rastegari A; Homayouni Moghadam F; Najafi Z
    Chem Biodivers; 2021 Jun; 18(6):e2000924. PubMed ID: 33861892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
    Camps P; El Achab R ; Morral J; Muñoz-Torrero D; Badia A; Baños JE; Vivas NM; Barril X; Orozco M; Luque FJ
    J Med Chem; 2000 Nov; 43(24):4657-66. PubMed ID: 11101357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
    Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
    Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
    Pourabdi L; Khoobi M; Nadri H; Moradi A; Moghadam FH; Emami S; Mojtahedi MM; Haririan I; Forootanfar H; Ameri A; Foroumadi A; Shafiee A
    Eur J Med Chem; 2016 Nov; 123():298-308. PubMed ID: 27484515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
    Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
    Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of multifunctional ligands targeting acetylcholinesterase and alpha 7 nicotinic acetylcholine receptor.
    Cieslikiewicz-Bouet M; Naldi M; Bartolini M; Pérez B; Servent D; Jean L; Aráoz R; Renard PY
    Biochem Pharmacol; 2020 Jul; 177():114010. PubMed ID: 32360492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homodimeric tacrine congeners as acetylcholinesterase inhibitors.
    Hu MK; Wu LJ; Hsiao G; Yen MH
    J Med Chem; 2002 May; 45(11):2277-82. PubMed ID: 12014965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, molecular docking and molecular dynamics studies of novel tacrine-carbamate derivatives as potent cholinesterase inhibitors.
    Ozten O; Zengin Kurt B; Sonmez F; Dogan B; Durdagi S
    Bioorg Chem; 2021 Oct; 115():105225. PubMed ID: 34364052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, docking study and biological evaluation of some novel tetrahydrochromeno [3',4':5,6]pyrano[2,3-b]quinolin-6(7H)-one derivatives against acetyl- and butyrylcholinesterase.
    Khoobi M; Alipour M; Moradi A; Sakhteman A; Nadri H; Razavi SF; Ghandi M; Foroumadi A; Shafiee A
    Eur J Med Chem; 2013 Oct; 68():291-300. PubMed ID: 23988412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer's disease.
    Rastegari A; Safavi M; Vafadarnejad F; Najafi Z; Hariri R; Bukhari SNA; Iraji A; Edraki N; Firuzi O; Saeedi M; Mahdavi M; Akbarzadeh T
    Mol Divers; 2022 Feb; 26(1):409-428. PubMed ID: 34273065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Design, synthesis and evaluation of tacrine-methoxybenzene hybrids as cholinesterases inhibitors].
    Luo W; Zhao YM; Zhang Z; Su YB; Wang CJ
    Yao Xue Xue Bao; 2012 Jul; 47(7):916-21. PubMed ID: 22993857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
    Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
    J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of tacrine-lophine hybrids via one-pot four component reaction and biological evaluation as acetyl- and butyrylcholinesterase inhibitors.
    da Costa JS; Lopes JP; Russowsky D; Petzhold CL; Borges AC; Ceschi MA; Konrath E; Batassini C; Lunardi PS; Gonçalves CA
    Eur J Med Chem; 2013 Apr; 62():556-63. PubMed ID: 23422935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
    Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
    J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New tacrine-derived AChE/BuChE inhibitors: Synthesis and biological evaluation of 5-amino-2-phenyl-4H-pyrano[2,3-b]quinoline-3-carboxylates.
    Eghtedari M; Sarrafi Y; Nadri H; Mahdavi M; Moradi A; Homayouni Moghadam F; Emami S; Firoozpour L; Asadipour A; Sabzevari O; Foroumadi A
    Eur J Med Chem; 2017 Mar; 128():237-246. PubMed ID: 28189905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors.
    Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Asatouri R; Vafadarnejad F; Moghadam FH; Khanavi M; Sharifzadeh M; Akbarzadeh T
    Eur J Med Chem; 2017 Jan; 125():1200-1212. PubMed ID: 27863370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.